BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«SIGA Technologies

Below is an extended SIGA Technologies research listing. Click here to return to the SIGA Technologies main Biocorporate entry.

Recent Publications by SIGA Technologies:

Identification of a broad-spectrum arenavirus entry inhibitor.
Several arenaviruses, including Lassa virus (LASV), are causative agents...
1st November, 2008
SIGA Technologies, Inc., Corvallis, Oregon 97333, USA. J Virol. 2008 Nov;82(21):10768-75. Epub 2008 Aug 20.
DOI Direct Link
Single-dose safety and pharmacokinetics of ST-246, a novel orthopoxvirus egress inhibitor.
ST-246 is a novel, potent orthopoxvirus egress inhibitor that is being...
14th August, 2008
SIGA Technologies, Inc., 4575 SW Research Way, Corvallis, OR 97330, USA. Antimicrob Agents Chemother. 2008 May;52(5):1721-7. Epub 2008 Mar 3.
DOI Direct Link
Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge.
The potential threat of smallpox use in a bioterrorist attack has...
16th April, 2008
SIGA Technologies, Inc., 4575 SW Research Way, Suite 230, Corvallis, OR J Virol. 2008 Apr;82(7):3517-29. Epub 2008 Jan 16.
DOI Direct Link
Discovery and development of antiviral drugs for biodefense: experience of a small biotechnology company.
The unmet need for effective antivirals against potential agents of...
9th April, 2008
SIGA Technologies, Inc., 4575 SW Research Way Suite 230, Corvallis, OR Antiviral Res. 2008 Jan;77(1):1-5. Epub 2007 Aug 15.
DOI Direct Link
Immune responses to the smallpox vaccine given in combination with ST-246, a small-molecule inhibitor of poxvirus dissemination.
The re-emerging threat of smallpox and the emerging threat of monkeypox...
26th March, 2008
SIGA Technologies, 4575 SW Research Way, Suite 230, Corvallis, OR 97333, Vaccine. 2008 Feb 13;26(7):933-46. Epub 2007 Dec 26.
DOI Direct Link
Discovery of small molecule inhibitors of ubiquitin-like poxvirus proteinase I7L using homology modeling and covalent docking approaches.
Essential for viral replication and highly conserved among poxviridae, the...
12th February, 2008
SIGA Technologies, J Comput Aided Mol Des. 2007 Oct-Nov;21(10-11):549-58. Epub 2007 Oct 25.
DOI Direct Link
Comparison of transformation protocols in Streptococcus gordonii and evaluation of native promoter strength using a multiple-copy plasmid.
An active area of research in the development of Streptococcus gordonii...
19th September, 2007
Siga Technologies, Inc., 4575 SW Research Way, Suite 230, Corvallis, OR Can J Microbiol. 2007 Mar;53(3):417-26.
DOI Direct Link
Smallpox antiviral drug development: satisfying the animal efficacy rule.
Concerns over the potential use of variola virus as a biological weapon...
27th July, 2006
SIGA Technologies Expert Rev Anti Infect Ther. 2006 Apr;4(2):277-89.
DOI Direct Link
Vaccinia virus proteolysis--a review.
It is well known that viruses, as obligate intracellular parasites, must...
13th July, 2006
SIGA Technologies, Inc., Corvallis, Oregon 97333, USA. Rev Med Virol. 2006 May-Jun;16(3):187-202.
DOI Direct Link
Identification and characterization of potent small molecule inhibitor of hemorrhagic fever New World arenaviruses.
Category A arenaviruses as defined by the National Institute of Allergy...
7th June, 2006
SIGA Technologies Inc., 4575 SW Research Way, Corvallis, OR 97333, USA. Antiviral Res. 2006 Feb;69(2):86-97. Epub 2005 Nov 28.
DOI Direct Link
Listeria monocytogenes 10403S HtrA is necessary for resistance to cellular stress and virulence.
The HtrA serine protease has been shown to be essential for bacterial...
8th February, 2006
SIGA Technologies, 4575 NW Research Way, Corvallis, OR 97330, USA. Infect Immun. 2006 Jan;74(1):765-8.
DOI Direct Link
Commensal bacteria as a novel delivery system for subunit vaccines directed against agents of bioterrorism.
Following the anthrax attacks of 2001 and the recent SARS outbreak,...
28th September, 2005
SIGA Technologies, Inc., 4575 SW Research Way, Suite 230, Corvallis, OR Adv Drug Deliv Rev. 2005 Jun 17;57(9):1392-402. Epub 2005 Apr 14.
DOI Direct Link
Development of PLEX, a plasmid-based expression system for production of heterologous gene products by the gram-positive bacteria Streptococcus gordonii.
While Escherichia coli expression systems have been widely utilized for...
1st July, 2005
Siga Technologies, Inc., 4575 SW Research Way, Suite 230 Corvallis, OR Protein Expr Purif. 2005 Apr;40(2):319-26.
DOI Direct Link
Escherichia coli DegP protease cleaves between paired hydrophobic residues in a natural substrate: the PapA pilin.
The DegP protein, a multifunctional chaperone and protease, is essential...
29th October, 2002
SIGA Technologies, Inc., J Bacteriol. 2002 Oct;184(20):5762-71.

«SIGA Technologies

This page contained an extended SIGA Technologies research listing. Click here to return to the SIGA Technologies main Biocorporate entry.

  Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2008 - BioPortfolio Limited.